BRCA1 expression, its correlation with clinicopathological features, and response to neoadjuvant chemotherapy in high-grade serous ovarian cancer.

导出原文传递

翻译打印收藏纠错

第一作者： Akkamahadevi,Patil

第一单位： Department of Histopathology, Kidwai Memorial Institute of Oncology, Bangalore, India.

作者： Akkamahadevi,Patil ^[1] ; Sharada,Patil ^[2] ; C E,Anupama ^[2] ; Savitha,Rajarajan ^[2] ; Vidya P,Nimbalkar ^[2] ; Usha,Amirtham ^[1] ; G,Champaka ^[1] ; M N,Suma ^[1] ; Geetha V,Patil ^[1] ; Ashwini,Nargund ^[1] ; V R,Pallavi ^[3] ; Linu,Jacob ^[4] ; C S,Premalatha ^[1] ; Jyothi S,Prabhu ^[2]

作者单位： Department of Histopathology, Kidwai Memorial Institute of Oncology, Bangalore, India. ^[1] Division of Molecular Medicine, St. John's Research Institute, St John's Medical College, Bangalore, India. ^[2] Department of Gynecological Oncology, Kidwai Memorial Institute of Oncology, Bangalore, India. ^[3] Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, India. ^[4]

关键词 BRCA1 dysfunction HG-SOC ID4 NACT response

主题词人类(Humans);女(雌)性(Female);BRCA1蛋白质(BRCA1 Protein);肿瘤辅助疗法(Neoadjuvant Therapy);卵巢肿瘤(Ovarian Neoplasms);RNA, 信使(RNA, Messenger)

DOI 10.1111/jog.15796

PMID 37737055

发布时间 2023-12-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交